98 related articles for article (PubMed ID: 22409183)
1. Inhibiting CD164 expression in colon cancer cell line HCT116 leads to reduced cancer cell proliferation, mobility, and metastasis in vitro and in vivo.
Tang J; Zhang L; She X; Zhou G; Yu F; Xiang J; Li G
Cancer Invest; 2012 Jun; 30(5):380-9. PubMed ID: 22409183
[TBL] [Abstract][Full Text] [Related]
2. [Effect of stromal cell-derived factor-1 and its receptor CXCR4 on liver metastasis of human colon cancer].
Ding YL; Fu QY; Tang SF; Zhang JL; Li ZY; Li ZT
Zhonghua Wai Ke Za Zhi; 2009 Feb; 47(3):210-3. PubMed ID: 19563077
[TBL] [Abstract][Full Text] [Related]
3. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases.
Zeelenberg IS; Ruuls-Van Stalle L; Roos E
Cancer Res; 2003 Jul; 63(13):3833-9. PubMed ID: 12839981
[TBL] [Abstract][Full Text] [Related]
4. [Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer].
Ding YL; Zhang JL; Tang SF; Fu QY; Li ZT
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):202-5. PubMed ID: 18361822
[TBL] [Abstract][Full Text] [Related]
5. The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis.
Havens AM; Jung Y; Sun YX; Wang J; Shah RB; Bühring HJ; Pienta KJ; Taichman RS
BMC Cancer; 2006 Jul; 6():195. PubMed ID: 16859559
[TBL] [Abstract][Full Text] [Related]
6. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A
FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966
[TBL] [Abstract][Full Text] [Related]
7. CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer.
Zhang XG; Zhang T; Li CY; Zhang MH; Chen FM
Cancer Med; 2018 Aug; 7(8):3763-3772. PubMed ID: 30022623
[TBL] [Abstract][Full Text] [Related]
8. Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells.
Zhu F; Zykova TA; Kang BS; Wang Z; Ebeling MC; Abe Y; Ma WY; Bode AM; Dong Z
Gastroenterology; 2007 Jul; 133(1):219-31. PubMed ID: 17631144
[TBL] [Abstract][Full Text] [Related]
9. CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1α/CXCR4 axis.
Huang AF; Chen MW; Huang SM; Kao CL; Lai HC; Chan JY
Mol Cancer; 2013 Oct; 12(1):115. PubMed ID: 24094005
[TBL] [Abstract][Full Text] [Related]
10. C2GnT-M is downregulated in colorectal cancer and its re-expression causes growth inhibition of colon cancer cells.
Huang MC; Chen HY; Huang HC; Huang J; Liang JT; Shen TL; Lin NY; Ho CC; Cho IM; Hsu SM
Oncogene; 2006 Jun; 25(23):3267-76. PubMed ID: 16418723
[TBL] [Abstract][Full Text] [Related]
11. [Chemokine receptor CXCR4 gene silencing with shRNA inhibits breast cancer metastasis to the lung in nude mice].
Zhang MX; Han N; Yu SY; Leng Y
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):325-9. PubMed ID: 18953828
[TBL] [Abstract][Full Text] [Related]
12. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
Sun YX; Schneider A; Jung Y; Wang J; Dai J; Wang J; Cook K; Osman NI; Koh-Paige AJ; Shim H; Pienta KJ; Keller ET; McCauley LK; Taichman RS
J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
[TBL] [Abstract][Full Text] [Related]
13. Role of CXCL12 in metastasis of human ovarian cancer.
Jiang YP; Wu XH; Xing HY; DU XY
Chin Med J (Engl); 2007 Jul; 120(14):1251-5. PubMed ID: 17697577
[TBL] [Abstract][Full Text] [Related]
14. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
15. [Effects of chemokine receptor and its ligand on migration of ovarian cancer cells].
Li F; Zhu HS; Han ZQ; Chen G; Gao QL; Jia P; Zhang AL; Xi L; Xu Q; Liao GN; Wang SX; Lu YP; Ma D
Ai Zheng; 2005 Jan; 24(1):23-7. PubMed ID: 15642195
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms involved in biological behavior changes associated with Angptl4 expression in colon cancer cell lines.
Huang XF; Han J; Hu XT; He C
Oncol Rep; 2012 May; 27(5):1541-7. PubMed ID: 22307217
[TBL] [Abstract][Full Text] [Related]
17. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
Chinni SR; Sivalogan S; Dong Z; Filho JC; Deng X; Bonfil RD; Cher ML
Prostate; 2006 Jan; 66(1):32-48. PubMed ID: 16114056
[TBL] [Abstract][Full Text] [Related]
18. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
19. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer.
Yasumoto K; Yamada T; Kawashima A; Wang W; Li Q; Donev IS; Tacheuchi S; Mouri H; Yamashita K; Ohtsubo K; Yano S
Clin Cancer Res; 2011 Jun; 17(11):3619-30. PubMed ID: 21482691
[TBL] [Abstract][Full Text] [Related]
20. RP11‑619L19.2 promotes colon cancer development by regulating the miR‑1271‑5p/CD164 axis.
Zhang XW; Li SL; Zhang D; Sun XL; Zhai HJ
Oncol Rep; 2020 Dec; 44(6):2419-2428. PubMed ID: 33125110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]